Commodore Capital

Commodore Capital is a healthcare investment firm. We use a science-driven approach to invest in innovative companies that are developing medical products to meaningfully improve patients’ lives. The fund is designed to make long-term investments in small-cap public and late-stage private biopharmaceutical companies. We are investing in innovative companies to improve patients’ lives. We believe that we are in the early stages of a major innovation cycle in biopharmaceuticals. At Commodore, we strive to be good partners to these companies as they work to bring safe and effective new medicines to patients around the world.